Cedars-Sinai bootcamp gives health-tech startups a boost

For many people, “bootcamp” may make one think of an intense workout. But for eight health-tech startups, the phrase means an opportunity to grow. Cedars-Sinai in Los Angeles, California has selected eight health-tech startups, out of 650, to join its three-month bootcamp to develop innovations and products to improve patient care.

The second batch of startups to go through the Cedars-Sinai Accelerator, powered by the mentoring startup accelerator company Techstars, will receive mentoring from physicians and executives, $120,000 to develop their innovations and access to Techstars’ network of entrepreneurs.

“We’re excited to pair these bright, motivated entrepreneurs with healthcare experts from Cedars-Sinai who together can rapidly accelerate the pace of innovation and transform healthcare in meaningful ways for our patients,” said Darren Dworkin, senior vice president and chief information officer at Cedars-Sinai.

The eight tech startups include:

  • Cerebro Solutions: An online platform that assists in managing clinicians and labor costs while predicting labor demands.
  • FIGS: An e-commerce platform that sells updated medical apparel featuring tailored, fluid-resistant fabrics.
  • Frame Health: Software that uses personality analysis to identify high-cost, non-adherent patients and personalize treatment plans to reduce costs and improve adherence and outcomes. 
  • Healthcare TTU: A platform providing predictive analytics for cash flows and valuation of accounts receivable to increase financing opportunities.
  • HealthTensor: Develops artificial intelligence to improve patient outcomes and reduce costs.
  • Noteworth: Unites smart medical devices, data and support into a single, interoperable platform to deliver more efficient care.
  • ReferralMD:  A cloud-based service that expedites physician referrals and e-consults with other doctors.
""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.